Arvinas, Inc. (Nasdaq: ARVN) has elevated Randy Teel, Ph.D., to the position of President and Chief Executive Officer, effective February 12, 2026. The appointment marks a significant leadership transition at the clinical-stage biotechnology company pioneering targeted protein degradation